Perspective: Phase Amplitude Coupling-Based Phase-Dependent Neuromodulation in Parkinson's Disease.

Area of Science:

• Neuroscience
• Biomedical Engineering
• Neuromodulation

Background:

• Deep brain stimulation (DBS) is a current standard for Parkinson's disease (PD) treatment.
• Limitations in current DBS necessitate adaptive neuromodulation systems for dynamic therapeutic adjustments.
• Focus is shifting from high-frequency cortical stimulation to subcortical targets and precise timing.

Purpose of the Study:

• To explore novel neuromodulation paradigms for Parkinson's disease.
• To identify biomarkers for adaptive brain stimulation systems.
• To investigate the potential of beta-gamma phase amplitude coupling (PAC) as a biomarker for real-time neuromodulation.

Main Methods:

• Analysis of neuronal activity patterns, specifically beta-gamma phase amplitude coupling (PAC) in the motor cortex.
• Correlation of PAC with Parkinson's disease motor signs and symptoms.
• Exploration of phase-dependent stimulation techniques for precise neuromodulation.

Main Results:

• Beta-gamma PAC in the motor cortex is a strong biomarker for PD motor symptoms.
• PAC levels correlate with therapeutic response in a dose-dependent manner.
• PAC may reflect the overall state of the parkinsonian motor network with stable fluctuations.

Conclusions:

• Beta-gamma PAC shows potential as a biomarker to drive next-generation adaptive brain stimulation.
• Phase-dependent stimulation techniques could enable precise, real-time modulation of pathological brain activity.
• Overcoming technical challenges may lead to less invasive, more effective PD therapies with fewer side effects.